Skip to main content

Table 4 Effect size for the SF-36 and the VascuQoL at three, six and 12 months

From: Impact of walk advice alone or in combination with supervised or home-based structured exercise on patient-reported physical function and generic and disease-specific health related quality of life in patients with intermittent claudication, a secondary analysis in a randomized clinical trial

 

HSEP

SEP

WA

Variable

3 months

6 months

12 months

3 months

6 months

12 months

3 months

6 months

12 months

PF

Small

Small

Small

Small

Small

Moderate

Small

Small

Moderate

RP

Small

 

Small

 

Small

Small

  

Small

BP

Small

Small

Moderate

Small

Small

Moderate

 

Small

 

GH

 

Small

 

Small

     

VT

     

Small

   

SF

        

Small

RE

Small

Small

   

Small

Small

 

Small

MH

Small

    

Small

   

PCS

Small

Small

Small

Small

Small

Small

Small

Small

Small

MCS

         

Activity

Moderate

Small

Small

Moderate

Small

Moderate

 

Small

Small

Symptom

Small

 

Small

 

Small

Small

   

Pain

Small

Small

Small

Moderate

Moderate

Moderate

  

Small

Emotional

Small

Small

Small

Small

Small

Small

   

Social

Small

  

Small

Small

Moderate

Small

Small

Small

Summary Score

Small

Small

Small

Small

Small

Moderate

  

Small

  1. Effect size: small = 0.2 to < 0.5; moderate = 0.5 to < 0.8; large > 0.8. Empty table panel indicate no effect size (unchanged)
  2. HSEP Home-based structured supervised exercise program. SEP hospital-based supervised exercise program, WA Walk advice. PF Physical functioning, RP Role physical, BP Bodily pain, MH Mental health, RE Role emotional, SF Social functioning, VT Vitality and GH General health, PCS Physical component summary, MCS Mental component summary